Search results for "Opioids"
FDA considers new approach to safe disposal of opioids
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/06/fda-considers-new-approach-to-safe-disposal-of-opioids.htm
1 Jun 2022
Some serious risks of long-term opioid therapy may be dose-dependent
Long-term opioid therapy is associated with increased risk for serious harms such as overdose, opioid abuse, fractures, and myocardial infarction, and some of the effect may be dose-dependent, according to a systematic review.
https://immattersacp.org/weekly/archives/2015/01/13/1.htm
13 Jan 2015
Extended-release morphine didn't improve breathlessness in COPD
Patients with chronic obstructive pulmonary disease (COPD) randomized to two different doses of morphine or placebo for three weeks reported similar effects on breathlessness, an Australian trial found. Their step count also didn't change.
https://immattersacp.org/weekly/archives/2022/11/29/1.htm
29 Nov 2022
Neurologists suggest steps for prescribing opioids for chronic pain
The American Academy of Neurology issued a position paper outlining steps that can help physicians who prescribe chronic opioid analgesic therapy (COAT) for chronic noncancer pain (CNCP).
https://immattersacp.org/weekly/archives/2014/10/07/1.htm
7 Oct 2014
‘Considerable uncertainty’ surrounds efficacy, safety of analgesics for low back pain
A systematic review and meta-analysis of 98 randomized controlled trials found little high-certainty evidence on the comparative effectiveness and safety of analgesics for acute nonspecific low back pain.
https://immattersacp.org/weekly/archives/2023/03/28/1.htm
28 Mar 2023
Nonopioids effective for acute low back pain, review finds
Myorelaxants and NSAIDs with or without acetaminophen were all effective at reducing pain and disability from acute, nonspecific low back pain lasting less than 12 weeks, according to an analysis of 18 randomized controlled trials, although the authors stressed that medications for this condition should always be a second-line strategy.
https://immattersacp.org/weekly/archives/2023/02/28/1.htm
28 Feb 2023
Deaths from stimulant use rose sharply in the past decade
Mortality from stimulants, including cocaine and methamphetamine, rose faster than deaths from opioids from 2010 to 2017, according to data from the National Center for Health Statistics.
https://immattersacp.org/weekly/archives/2021/02/09/4.htm
9 Feb 2021
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023
Few high-quality guidelines exist for prescribing opioids
Few high-quality guidelines exist for prescribing opioids to treat chronic pain, a review found, noting that there was at least consensus among guidelines on ways to mitigate opioid-related risks.
https://immattersacp.org/weekly/archives/2013/11/12/1.htm
12 Nov 2013